These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29250737)

  • 1. A prospective observational study of problematic oral cannabinoid use.
    Ware MA; Martel MO; Jovey R; Lynch ME; Singer J
    Psychopharmacology (Berl); 2018 Feb; 235(2):409-417. PubMed ID: 29250737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey.
    Khelemsky Y; Goldberg AT; Hurd YL; Winkel G; Ninh A; Qian L; Oprescu A; Ciccone J; Katz DJ
    Reg Anesth Pain Med; 2017; 42(5):652-659. PubMed ID: 28796754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Properties of the Turkish Versions of the Cannabis Use Problems Identification Test (CUPIT) and the Adult Cannabis Problems Questionnaire (CPQ).
    Evren C; Yilmaz Cengel H; Bozkurt M; Evren B; Umut G; Agachanli R
    J Psychoactive Drugs; 2017; 49(1):83-89. PubMed ID: 28195831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic cannabinoid use among patients in residential substance use disorder treatment: prevalence, motives, and correlates.
    Bonar EE; Ashrafioun L; Ilgen MA
    Drug Alcohol Depend; 2014 Oct; 143():268-71. PubMed ID: 25096272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and the brain.
    Castle DJ; Ames FR
    Aust N Z J Psychiatry; 1996 Apr; 30(2):179-83. PubMed ID: 8811260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid use among college students.
    Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
    Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Psychiatric Consequences of Cannabinoids.
    De Aquino JP; Sherif M; Radhakrishnan R; Cahill JD; Ranganathan M; D'Souza DC
    Clin Ther; 2018 Sep; 40(9):1448-1456. PubMed ID: 29678279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
    Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
    Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis.
    Mensen VT; Vreeker A; Nordgren J; Atkinson A; de la Torre R; Farré M; Ramaekers JG; Brunt TM
    Psychopharmacology (Berl); 2019 Sep; 236(9):2677-2685. PubMed ID: 30968175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder.
    Cengel HY; Bozkurt M; Evren C; Umut G; Keskinkilic C; Agachanli R
    Psychiatry Res; 2018 Apr; 262():46-54. PubMed ID: 29407568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
    Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
    Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington.
    Davis KC; Allen J; Duke J; Nonnemaker J; Bradfield B; Farrelly MC; Shafer P; Novak S
    PLoS One; 2016; 11(1):e0146853. PubMed ID: 26800209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contributions of parental and social influences to cannabis use in a non-clinical sample of adolescents].
    Chabrol H; Mabila JD; Chauchard E; Mantoulan R; Rousseau A
    Encephale; 2008 Jan; 34(1):8-16. PubMed ID: 18514145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
    Ralphs R; Williams L; Askew R; Norton A
    Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of synthetic cannabinoid use in Australia.
    Barratt MJ; Cakic V; Lenton S
    Drug Alcohol Rev; 2013 Mar; 32(2):141-6. PubMed ID: 23043552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety issues concerning the medical use of cannabis and cannabinoids.
    Ware MA; Tawfik VL
    Pain Res Manag; 2005; 10 Suppl A():31A-7A. PubMed ID: 16237480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg.
    Tanda G
    Psychopharmacology (Berl); 2016 May; 233(10):1845-66. PubMed ID: 27026633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probability and correlates of dependence among regular users of alcohol, nicotine, cannabis, and cocaine: concurrent and prospective analyses of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Cougle JR; Hakes JK; Macatee RJ; Zvolensky MJ; Chavarria J
    J Clin Psychiatry; 2016 Apr; 77(4):e444-50. PubMed ID: 27137428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.